+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East Human Papilloma Virus Testing Market Size, Share & Trends Analysis Report by Application (Cervical Cancer Screening, Vaginal Cancer Screening), by Product (Instruments, Consumables), by Technology, by End-use, by Country, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 200 Pages
  • August 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6168244
REQUEST CUSTOMIZATION
Description Jump to:
The Middle East human papilloma virus testing market size was estimated at USD 60.02 million in 2024 and is projected to reach USD 203.37 million by 2033, growing at a CAGR of 14.80% from 2025 to 2033. Low HPV vaccine awareness and acceptance in the Middle East, driven by limited inclusion in national immunization programs, creates a stronger reliance on testing for early detection. Government-led screening campaigns, women’s health initiatives, and expansion of diagnostic infrastructure are supporting growth. Advancements in molecular diagnostics and self-collection technologies, even if not yet regionally approved, are influencing adoption strategies through pilot programs and private sector offerings. While cervical cancer incidence remains below global averages, changing demographics, evolving sexual behaviors, and cultural barriers to vaccination are prompting policymakers and healthcare providers to invest in HPV testing as a proactive measure to mitigate future disease burden.

The industry is evolving, shaped by policy initiatives, technology adoption, and varying levels of public awareness. While cervical cancer incidence in most countries remains below global averages, growing recognition of HPV’s broader health impact is prompting gradual expansion of screening and vaccination programs. Regional meta-analyses indicate that HPV vaccine awareness averages in the low 40% range, with higher levels in countries where the vaccine is part of the national immunization schedule. For example, Israel’s longstanding program reports awareness levels above 80%, whereas in markets without formal inclusion-such as Palestine-awareness remains extremely low. Within the Gulf Cooperation Council (GCC), countries such as the UAE and Saudi Arabia show higher awareness and acceptance, aligned with more structured public health interventions.

Middle East Human Papilloma Virus Testing Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the Middle East human papilloma virus testing market report on the basis of application, product, technology, end use, and country:

Application Outlook (Revenue, USD Million, 2021-2033)

  • Cervical Cancer Screening
  • Vaginal Cancer Screening

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments
  • Consumables
  • Services

Technology Outlook (Revenue, USD Million, 2021-2033)

  • PCR
  • Immunodiagnostics
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics
  • Laboratories
  • Others

Country Outlook (Revenue, USD Million, 2021-2033)

  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Product
1.2.3. Technology
1.2.4. End Use
1.2.5. Regional Scope
1.2.6. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Outlook
2.2.2. Product Outlook
2.2.3. Technology Outlook
2.2.4. End Use Outlook
2.2.5. Regional Outlook
2.3. Competitive Scenario
Chapter 3. ME Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. ME Human Papilloma Virus (HPV) Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. ME Human Papilloma Virus (HPV) Testing Market: Application Estimates & Trend Analysis
4.1. Application Segment Dashboard
4.2. ME Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
4.3. ME Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.4. Cervical Cancer Screening
4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.5. Vaginal Cancer Screening
4.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 5. ME Human Papilloma Virus (HPV) Testing Market: Product Estimates & Trend Analysis
5.1. Product Segment Dashboard
5.2. ME Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
5.3. ME Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Instruments
5.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.5. Consumables
5.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.6. Services
5.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 6. ME Human Papilloma Virus (HPV) Testing Market: Technology Estimates & Trend Analysis
6.1. Technology Segment Dashboard
6.2. ME Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
6.3. ME Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. PCR
6.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.5. Immunodiagnostics
6.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.6. Others
6.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 7. ME Human Papilloma Virus (HPV) Testing Market: End Use Estimates & Trend Analysis
7.1. End Use Segment Dashboard
7.2. ME Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
7.3. ME Human Papilloma Virus (HPV) Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals & Clinics
7.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.5. Laboratories
7.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.6. Others
7.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 8. ME Human Papilloma Virus (HPV) Testing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2033
8.3. ME Human Papilloma Virus (HPV) Testing Market by Region: Key Takeaways
8.4. Middle East
8.4.1. Middle East Market Estimates and Forecasts 2021 to 2033 (USD Million)
8.4.2. Saudi Arabia
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Framework/ Reimbursement Structure
8.4.2.3. Competitive Scenario
8.4.2.4. Saudi Arabia Market Estimates and Forecasts 2021 to 2033 (USD Million)
8.4.3. UAE
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Framework/ Reimbursement Structure
8.4.3.3. Competitive Scenario
8.4.3.4. UAE Market Estimates and Forecasts 2021 to 2033 (USD Million)
8.4.4. Kuwait
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Framework/ Reimbursement Structure
8.4.4.3. Competitive Scenario
8.4.4.4. Kuwait Market Estimates and Forecasts 2021 to 2033 (USD Million)
8.4.5. Oman
8.4.5.1. Key Country Dynamics
8.4.5.2. Regulatory Framework/ Reimbursement Structure
8.4.5.3. Competitive Scenario
8.4.5.4. QatarMarket Estimates and Forecasts 2021 to 2033 (USD Million)
8.4.6. Qatar
8.4.6.1. Key Country Dynamics
8.4.6.2. Regulatory Framework/ Reimbursement Structure
8.4.6.3. Competitive Scenario
8.4.6.4. QatarMarket Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/ Competition Categorization
9.3. Vendor Landscape
9.3.1. Key Company Heat Map Analysis, 2024
9.4. Company Profiles
9.4.1. Abbott
9.4.1.1. Company Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Biomedical Diagnostics
9.4.2.1. Company Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. bioMerieux
9.4.3.1. Company Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Bio-Rad Laboratories, Inc.
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Fujirebio
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Oncolab
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Hologic, Inc.
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Qiagen
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. F. Hoffmann-La Roche Ltd
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Siemens Healthineers AG
9.4.10.1. Company Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 ME Human Papilloma Virus (HPV) Testing Market, by Region, 2021-2033 (USD Million)
Table 4 ME Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 5 ME Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 6 ME Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 7 ME Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
Table 8 ME Human Papilloma Virus (HPV) Testing Market, by Country, 2021-2033 (USD Million)
Table 9 ME Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 10 ME Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 11 ME Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 12 ME Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
Table 13 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 14 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 15 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 16 Saudi Arabia Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
Table 17 UAE Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 18 UAE Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 19 UAE Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 20 UAE Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
Table 21 Kuwait Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 22 Kuwait Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 23 Kuwait Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 24 Kuwait Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
Table 25 Qatar Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 26 Qatar Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 27 Qatar Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 28 Qatar Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
Table 29 Oman ME Human Papilloma Virus (HPV) Testing Market, by Application, 2021-2033 (USD Million)
Table 30 Oman ME Human Papilloma Virus (HPV) Testing Market, by Product, 2021-2033 (USD Million)
Table 31 Oman ME Human Papilloma Virus (HPV) Testing Market, by Technology, 2021-2033 (USD Million)
Table 32 Oman ME Human Papilloma Virus (HPV) Testing Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 ME Human Papilloma Virus (HPV) Testing Market: Market Outlook
Figure 10 ME Human Papilloma Virus (HPV) Testing Competitive Insights
Figure 11 Parent Market Outlook
Figure 12 Related/Ancillary Market Outlook
Figure 13 Penetration and Growth Prospect Mapping
Figure 14 Industry Value Chain Analysis
Figure 15 ME Human Papilloma Virus (HPV) Testing Market Driver Impact
Figure 16 ME Human Papilloma Virus (HPV) Testing Market Restraint Impact
Figure 17 ME Human Papilloma Virus (HPV) Testing Market Strategic Initiatives Analysis
Figure 18 ME Human Papilloma Virus (HPV) Testing Market: Application Movement Analysis
Figure 19 ME Human Papilloma Virus (HPV) Testing Market: Application Outlook and Key Takeaways
Figure 20 Cervical Cancer Screening Market Estimates and Forecast, 2021-2033
Figure 21 Vaginal Cancer Screening Market Estimates and Forecast, 2021-2033
Figure 22 ME Human Papilloma Virus (HPV) Testing Market: Product Movement Analysis
Figure 23 ME Human Papilloma Virus (HPV) Testing Market: Product Outlook and Key Takeaways
Figure 24 Instruments Market Estimates and Forecast, 2021-2033
Figure 25 Consumables Market Estimates and Forecast, 2021-2033
Figure 26 Services Market Estimates and Forecast, 2021-2033
Figure 27 ME Human Papilloma Virus (HPV) Testing Market: Technology Movement Analysis
Figure 28 ME Human Papilloma Virus (HPV) Testing Market: Technology Outlook and Key Takeaways
Figure 29 PCR Market, 2021-2033 (USD Million)
Figure 30 Immunodiagnostics Market, 2021-2033 (USD Million)
Figure 31 Others Market, 2021-2033 (USD Million)
Figure 32 ME Human Papilloma Virus (HPV) Testing Market: End Use Movement Analysis
Figure 33 ME Human Papilloma Virus (HPV) Testing Market: End Use Outlook and Key Takeaways
Figure 34 Hospitals & Clinics Market, 2021-2033 (USD Million)
Figure 35 Laboratories Market, 2021-2033 (USD Million)
Figure 36 Others Market, 2021-2033 (USD Million)
Figure 37 ME Human Papilloma Virus (HPV) Testing Market: Regional Movement Analysis
Figure 38 ME Human Papilloma Virus (HPV) Testing Market: Regional Outlook and Key Takeaways
Figure 39 Saudi Arabia Market Estimates and Forecasts, 2021-2033
Figure 40 UAE Market Estimates and Forecasts, 2021-2033
Figure 41 Kuwait Market Estimates and Forecasts, 2021-2033
Figure 42 Qatar Market Estimates and Forecasts, 2021-2033
Figure 43 Oman Market Estimates and Forecasts, 2021-2033

Companies Mentioned

The major companies profiled in this Middle East Human Papilloma Virus Testing market report include:
  • Abbott
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Fujirebio
  • Oncolab
  • Hologic, Inc.
  • Qiagen
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages200
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 60.02 Million
Forecasted Market Value ( USD ) by 2033 $ 203.37 Million
Compound Annual Growth Rate14.8%
Regions CoveredMiddle East
No. of Companies Mentioned10

Related Topics

Related Reports

Human Papilloma Virus Testing Market Size, Share & Trends Analysis Report by Application (Cervical Cancer Screening, Vaginal Cancer Screening), by Product, by Technology, by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

Human Papilloma Virus Testing Market Size, Share & Trends Analysis Report by Application (Cervical Cancer Screening, Vaginal Cancer Screening), by Product, by Technology, by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 110 Pages
  • Global
From
Human Papilloma Virus Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Human Papilloma Virus Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Virus Testing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Virus Testing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Zika Virus Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Zika Virus Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Zika Virus Testing - Global Strategic Business Report - Product Image

Zika Virus Testing - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.